Lilly Marks biography
Lilly Marks is Independent Director of the Company since June 2015. Since 2010, Ms. Marks has served as Vice President for Health Affairs for the University of Colorado and Anschutz Medical Campus, which includes the university’s Schools of Medicine, Dental Medicine, Pharmacy, Public Health, College of Nursing and Graduate School and the University of Colorado Hospital and Children’s Hospital Colorado. Prior to her health campus leadership role, Ms. Marks spent two decades as both Senior Associate Dean for Finance and Administration at the School Of Medicine and Executive Director of University Physicians, Inc., the 501(c)(3) faculty practice plan. Ms. Marks has served as Chair, Board of Directors of the University of Colorado Hospital and is currently chair of the board of the Association of American Medical Colleges and is a board member of the Board of Directors of the Federal Reserve Bank of Kansas City, the Fitzsimons Redevelopment Authority, the Association of Academic Health Centers (AAHC), the Global Down Syndrome Foundation, and the Rose Community Foundation. She is also a member of the AAMC Advisory Panel on Research and is a trustee of the University of Colorado Foundation.
What is the salary of Lilly Marks?
As the Independent Director of Orthofix Medical Inc, the total compensation of Lilly Marks at Orthofix Medical Inc is $250,558. There are 13 executives at Orthofix Medical Inc getting paid more, with Jon Serbousek having the highest compensation of $4,076,200.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
How old is Lilly Marks?
Lilly Marks is 72, she's been the Independent Director of Orthofix Medical Inc since 2015. There are 1 older and 16 younger executives at Orthofix Medical Inc. The oldest executive at Orthofix Medical Inc is Ronald Matricaria, 77, who is the Independent Chairman of the Board.
What's Lilly Marks's mailing address?
Lilly's mailing address filed with the SEC is 3451 PLANO PARKWAY, , LEWISVILLE, TX, 75056.
Insiders trading at Orthofix Medical Inc
Over the last 22 years, insiders at Orthofix Medical Inc have traded over $19,062,472 worth of Orthofix Medical Inc stock and bought 182,076 units worth $5,806,101 . The most active insiders traders include Stuart Essig, Charles R. Kummeth a Alexis V Lukianov. On average, Orthofix Medical Inc executives and independent directors trade stock every 53 days with the average trade being worth of $179,237. The most recent stock trade was executed by Kevin J. Kenny on 8 January 2024, trading 5,959 units of OFIX stock currently worth $103,687.
What does Orthofix Medical Inc do?
orthofix international began in a small farmhouse in verona italy in 1980 when orthopedic researcher giovanni de bastiani recognized the bone’s natural repair capability, a concept he called “dynamization” and with that in mind, he created the first external fixation device. today, orthofix has grown to more than 900 employees with locations in the u.s., italy, germany, france, the uk, brazil, australia and puerto rico. our products help patients in 70 countries around the world. the company is comprised of four strategic business units; biostim, biologics, extremity fixation and spine fixation. our products are widely distributed via the company's sales representatives, distributors and subsidiaries. at orthofix we are committed to clinical research and driven by new product introductions. we are proud of our strong partnerships with organizations such as the texas scottish rite hospital for children in dallas and the musculoskeletal transplant foundation. we take pride in developing
What does Orthofix Medical Inc's logo look like?
Orthofix Medical Inc executives and stock owners
Orthofix Medical Inc executives and other stock owners filed with the SEC include:
-
Jon Serbousek,
President, Chief Executive Officer, Director -
Douglas Rice,
Chief Financial Officer -
Kimberley Elting,
Chief Legal and Administrative Officer -
Jon C. Serbousek,
Pres, CEO & Director -
Kevin J. Kenny,
Pres of Global Spine Bus. -
Douglas C. Rice,
CFO & Chief Accounting Officer -
Kimberley A. Elting,
Chief Legal & Devel. Officer -
Ronald Matricaria,
Independent Chairman of the Board -
Paul W. Gonsalves,
Pres of Global Orthofix Orthopedics -
Michael Paolucci,
Independent Director -
James Hinrichs,
Independent Director -
Alexis Lukianov,
Independent Director -
Maria Sainz,
Independent Director -
Lilly Marks,
Independent Director -
John Sicard,
Independent Director -
Paul Gonsalves,
President of the Orthofix Global Extremities -
Jason Hannon,
Independent Director -
Kevin Kenny,
President, Global Orthofix Spine -
Suzanne Armstrong,
VP of HR -
Jill Mason,
Chief Ethics & Compliance Officer -
Dan E. Yarbrough,
VP of Investor Relations -
Tim McGuire,
Chief Information Officer -
Dr. James T. Ryaby B.A., Ph.D., Chemistry,
Chief Scientific Officer -
Roberto Donadello,
Sr. VP, Global Operations -
Michael Finegan,
-
Robert Allen Ii Goodwin,
President Biologics -
Rice Doug,
CFO -
Raymond Fujikawa,
President Spine Fixation -
Davide Bianchi,
President, Global Extremities -
Guy J Jordan,
Director -
Anthony Francis Martin,
Director -
Luke T Faulstick,
Director -
Bradley V. Niemann,
President of Global Spine -
Jeffrey Schumm,
SVP,General Counsel -
Charles R. Kummeth,
-
John J. Bostjancic,
CFO -
Keith Valentine,
President & CEO -
John B Iii Henneman,
-
Patrick L Keran,
Chief Legal Officer -
Stuart Essig,
Director -
Brad Mason,
CEO -
Massimo Calafiore,
President & CEO -
Eric M Brown,
Sr.V.P. of Sales and Marketing -
De Paul Alberto C Dabreu,
Director -
John W Littlechild,
Director -
Cooper Robert Gaines,
Chairman -
Davey Scoon,
Director -
Emily Buxton,
Int. Chief Financial Officer -
James Gero,
Director -
Wartburg Walter P Von,
Director -
Randy H Thurman,
Director -
Mark A Heggestad,
Chief Financial Officer -
Michael Mainelli,
Director -
Scott Dodson,
President, Orthopedics -
Kenneth R Weisshaar,
Director -
Kathleen T Regan,
Director -
Thomas M Hein,
Chief Financial Officer -
Gary Henley,
President, Americas Division -
Peter J Hewett,
Director -
Oliver Burckhardt,
President, International Div -
Alan Milinazzo,
Chief Operating Officer -
Galvin Mould,
President, International Div -
Frederik Hartsuiker,
Director -
Edgar Wallner,
Deputy Chairman -
Peter Clarke,
Executive Vice President -
Robert S Vaters,
Chief Financial Officer -
Stefan Widensohler,
Director -
Thomas J Kester,
Director -
Timothy M Adams,
Chief Financial Officer -
Charles Federico,
President & CEO -
Vicente Trelles,
SVP-Worldwide Operations -
Eric Brown,
President, Spinal Stimulation -
Michael Simpson,
President, Orthofix Inc. -
Bradley R Mason,
President of Breg -
Brian Mc Collum,
Interim CFO -
Jerry Benjamin,
Director -
Raymond C Kolls,
VP & General Counsel -
Bryan Mcmillan,
President, Spine GBU -
Brad Lee,
President, Breg -
Luigi Ferrari,
President, Int'l Fixation -
Shweta Maniar,
-
Julie Andrews,
CFO -
Patrick Fisher,
President, Global Orthopedics -
Jorge Andres Cedron,
CLO -
Wayne Burris,
-
Thomas A. West,
Director -
Puja Leekha,
CECO & Interim CLO -
Geoffrey C Gillespie,
CAO -
Catherine M Burzik,
-
Alan Lee Bazaar,
-
Max Reinhardt,
President, Global Spine